S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
Log in

OTCMKTS:ABVCAmerican Brivision (Holding) Stock Price, Forecast & News

$3.00
+0.05 (+1.69 %)
(As of 07/15/2020 04:00 PM ET)
Add
Compare
Today's Range
$3.00
Now: $3.00
$3.00
50-Day Range
$2.60
MA: $2.95
$3.00
52-Week Range
$1.05
Now: $3.00
$11.50
Volume400 shs
Average Volume1,553 shs
Market Capitalization$58.46 million
P/E RatioN/A
Dividend YieldN/A
Beta0.25
American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company's licensed products include ABV-1501, a combination therapy for triple negative breast cancer; ABV-1502, a combination therapy for solid tumors with Anti-PD1; ABV-1503, a combination therapy for chronic lymphocytic leukemia; ABV-1504 for depressive disorders; ABV-1505, a combination therapy for attention deficit hyperactivity disorder; BFC-1401, a vitreous substitute for vitrectomy; and Maitake combination therapy. It has a co-development agreement with Rgene Corporation to develop Maitake combination therapy products, such as ABV-1507 HER2/neu positive breast cancer combination therapy, ABV-1511 pancreatic cancer combination therapy, and ABV-1527 ovary cancer combination therapy; and collaborative agreements with BioLite Inc and BioFirst Corporation. The company was founded in 2015 and is based in Goshen, New York. American BriVision (Holding) Corporation is a subsidiary of YuanGene Corporation.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.76 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ABVC
CUSIPN/A
Phone845-291-1291

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$10,000.00

Profitability

Miscellaneous

Employees9
Market Cap$58.46 million
Next Earnings Date8/14/2020 (Estimated)
OptionableNot Optionable

Receive ABVC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABVC and its competitors with MarketBeat's FREE daily newsletter.

American Brivision (Holding) (OTCMKTS:ABVC) Frequently Asked Questions

How has American Brivision (Holding)'s stock been impacted by COVID-19 (Coronavirus)?

American Brivision (Holding)'s stock was trading at $2.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ABVC stock has increased by 3.4% and is now trading at $3.00. View which stocks have been most impacted by Coronavirus.

When is American Brivision (Holding)'s next earnings date?

American Brivision (Holding) is scheduled to release its next quarterly earnings announcement on Friday, August 14th 2020. View our earnings forecast for American Brivision (Holding).

Has American Brivision (Holding) been receiving favorable news coverage?

News coverage about ABVC stock has been trending extremely negative on Wednesday, InfoTrie Sentiment reports. The research firm rates the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. American Brivision (Holding) earned a media sentiment score of -4.3 on InfoTrie's scale. They also gave headlines about the company a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an impact on the stock's share price in the near term. View the latest news about American Brivision (Holding).

Who are some of American Brivision (Holding)'s key competitors?

Who are American Brivision (Holding)'s key executives?

American Brivision (Holding)'s management team includes the following people:
  • Mr. Eugene Jiang, Chairman & Interim CFO (Age 33)
  • Dr. Howard Doong, CEO & Pres (Age 62)
  • Dr. Chi-Hsin King, Chief Scientific Officer (Age 71)
  • Ms. Kira Huang, Consultant (Age 49)
  • Dr. Tsung-Shann Jiang, Chief Strategy Officer & Director (Age 64)

What is American Brivision (Holding)'s stock symbol?

American Brivision (Holding) trades on the OTCMKTS under the ticker symbol "ABVC."

How do I buy shares of American Brivision (Holding)?

Shares of ABVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is American Brivision (Holding)'s stock price today?

One share of ABVC stock can currently be purchased for approximately $3.00.

How big of a company is American Brivision (Holding)?

American Brivision (Holding) has a market capitalization of $58.46 million and generates $10,000.00 in revenue each year. American Brivision (Holding) employs 9 workers across the globe.

What is American Brivision (Holding)'s official website?

The official website for American Brivision (Holding) is www.ambrivis.com.

How can I contact American Brivision (Holding)?

American Brivision (Holding)'s mailing address is 44370 Old Warm Springs Blvd, Fremont CA, 94538. The company can be reached via phone at 845-291-1291.

This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.